{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T03:27:03Z","timestamp":1786505223910,"version":"build-2736575974"},"reference-count":284,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002713","name":"Imam Mohammed Ibn Saud Islamic University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023673","name":"Imam Mohammed Ibn Saud Islamic University Deanship of Scientific Research","doi-asserted-by":"publisher","award":["IMSIU-DDRSP2601"],"award-info":[{"award-number":["IMSIU-DDRSP2601"]}],"id":[{"id":"10.13039\/501100023673","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.prp.2026.156591","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:16:45Z","timestamp":1781651805000},"page":"156591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Liquid biopsy in gynecologic cancers: Cellular origin to early detection and precision care"],"prefix":"10.1016","volume":"286","author":[{"given":"Mokhtar","family":"Rejili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najma","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2026.156591_bib1","series-title":"Seminars in oncology nursing","article-title":"editors. Scope and epidemiology of gynecologic cancers: an overview","author":"Ledford","year":"2019"},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12032-023-01957-3","article-title":"Epidemiological trends and risk factors of gynecological cancers: an update","volume":"40","author":"Keyvani","year":"2023","journal-title":"Med. Oncol."},{"key":"10.1016\/j.prp.2026.156591_bib3","series-title":"Fundamentals in Gynaecologic Malignancy","first-page":"1","article-title":"Epidemiology of Gynaecological Cancers","author":"Kataki","year":"2023"},{"key":"10.1016\/j.prp.2026.156591_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/CLEP.S330081","article-title":"Trends in incidence and mortality of gynecological and breast cancers in Poland (1980-2018)","volume":"14","author":"Piechocki","year":"2022","journal-title":"Clin. Epidemiol."},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib5","article-title":"A systematic literature review of trials of survivorship interventions for women with gynaecological cancer and their caregivers","volume":"28","author":"Beesley","year":"2019","journal-title":"Eur. J. Cancer care"},{"issue":"20","key":"10.1016\/j.prp.2026.156591_bib6","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMsr2030640","article-title":"The IARC perspective on cervical cancer screening","volume":"385","author":"Bouvard","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib7","first-page":"229","article-title":"A review of cervical cancer: incidence and disparities","volume":"112","author":"Buskwofie","year":"2020","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.prp.2026.156591_bib8","series-title":"Journal of Physics: Conference Series","article-title":"A review: pap smear analysis based on image processing approach","author":"Mustafa","year":"2020"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12938-019-0634-5","article-title":"A pap-smear analysis tool (PAT) for detection of cervical cancer from pap-smear images","volume":"18","author":"William","year":"2019","journal-title":"Biomed. Eng. Online"},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ygyno.2022.03.019","article-title":"Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG)","volume":"165","author":"Henno","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3892\/ol.2023.14012","article-title":"Molecular biomarkers for facilitating genome\u2011directed precision medicine in gynecological cancer (Review)","volume":"26","author":"Minaguchi","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2026.156591_bib12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3389\/fcell.2019.00382","article-title":"Precise Personalized Medicine in Gynecology Cancer and Infertility","volume":"7","author":"Zhang","year":"2019","journal-title":"Front. Cell. Dev. Biol."},{"issue":"5","key":"10.1016\/j.prp.2026.156591_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41571-020-00457-x","article-title":"Liquid biopsy enters the clinic - implementation issues and future challenges","volume":"18","author":"Ignatiadis","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.prp.2026.156591_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103109","article-title":"ctDNA as a cancer biomarker: a broad overview","volume":"155","author":"Pessoa","year":"2020","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13048-020-00729-1","article-title":"Prediction of the treatment response in ovarian cancer: a ctDNA approach","volume":"13","author":"Sharbatoghli","year":"2020","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.prp.2026.156591_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2019.10.014","article-title":"Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: ready for prime time?","volume":"468","author":"Asante","year":"2020","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.prp.2026.156591_bib17","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.3390\/cancers12113382","article-title":"Comprehensive Gene Mutation Profiling of Circulating Tumor DNA in ovarian cancer: its pathological and prognostic impact","volume":"12","author":"Noguchi","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47030-w","article-title":"Liquid biopsy-based comprehensive gene mutation profiling for gynecological cancer using cancer personalized profiling by deep sequencing","volume":"9","author":"Iwahashi","year":"2019","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.prp.2026.156591_bib19","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.3390\/cancers13225731","article-title":"Diagnostic accuracy of liquid biopsy in endometrial cancer","volume":"13","author":"Lukasiewicz","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12943-022-01588-8","article-title":"Potential clinical utility of liquid biopsies in ovarian cancer","volume":"21","author":"Zhu","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc.2016.113","article-title":"The disparate origins of ovarian cancers: pathogenesis and prevention strategies","volume":"17","author":"Karnezis","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3802\/jgo.2015.26.2.83","article-title":"Ovarian cancer risk reduction through opportunistic salpingectomy","volume":"26","author":"Kwon","year":"2015","journal-title":"J. Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41698-023-00432-6","article-title":"Artificial intelligence in ovarian cancer histopathology: a systematic review","volume":"7","author":"Breen","year":"2023","journal-title":"NPJ Precis. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2026.156591_bib24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajog.2013.04.019","article-title":"The role of the fallopian tube in the origin of ovarian cancer","volume":"209","author":"Erickson","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib25","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1038\/s41467-018-06130-3","article-title":"Microenvironmental niche divergence shapes BRCA1-dysregulated ovarian cancer morphological plasticity","volume":"9","author":"Heindl","year":"2018","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.prp.2026.156591_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108930","article-title":"Ovarian cancer: advances in pathophysiology and therapies","volume":"24","author":"Tossetta","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156591_bib27","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3389\/fonc.2018.00654","article-title":"When Is \"Type I\" Ovarian Cancer Not \"Type I\"? indications of an out-dated dichotomy","volume":"8","author":"Salazar","year":"2018","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajog.2008.01.005","article-title":"Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis","volume":"198","author":"Kurman","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13048-021-00876-z","article-title":"Identification and clinical significance of somatic oncogenic mutations in epithelial ovarian cancer","volume":"14","author":"Watanabe","year":"2021","journal-title":"J. Ovarian Res."},{"issue":"14","key":"10.1016\/j.prp.2026.156591_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411570","article-title":"Combined Tumor-Based BRCA1\/2 and TP53 mutation testing in ovarian cancer","volume":"24","author":"Borcoman","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.prp.2026.156591_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10112694","article-title":"Combined Expression of HGFR with Her2\/neu, EGFR, IGF1R, Mucin-1 and integrin alpha2beta1 is associated with aggressive epithelial ovarian cancer","volume":"10","author":"Czogalla","year":"2022","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.prp.2026.156591_bib32","article-title":"Prognostic Value of KIF2A and HER2-Neu overexpression in patients with epithelial ovarian cancer","volume":"95","author":"Wang","year":"2016","journal-title":"Med. (Baltim. )"},{"issue":"15","key":"10.1016\/j.prp.2026.156591_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153681","article-title":"Traditional systemic treatment options in advanced low-grade serous ovarian cancer after successful cytoreduction: a systematic review and meta-analysis","volume":"14","author":"Montero-Macias","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1470-2045(19)30072-5","article-title":"Global elimination of cervical cancer as a public health problem","volume":"20","author":"Brisson","year":"2019","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.23736\/S0026-4784.19.04397-1","article-title":"Global strategies for cervical cancer prevention and screening","volume":"71","author":"Pimple","year":"2019","journal-title":"Minerva Ginecol."},{"issue":"10","key":"10.1016\/j.prp.2026.156591_bib36","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1158\/2159-8290.CD-NB2018-118","article-title":"Cervical Cancer Screening Every 5 Years OK","volume":"8","year":"2018","journal-title":"Cancer Discov."},{"issue":"9","key":"10.1016\/j.prp.2026.156591_bib37","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/dc.20527","article-title":"Routine vaginal Pap test is not useful in women status-post hysterectomy for benign disease","volume":"34","author":"Farghaly","year":"2006","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.prp.2026.156591_bib38","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.3389\/fmicb.2018.02896","article-title":"Involvement of human papillomaviruses in cervical cancer","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib39","first-page":"XE01","article-title":"J. Association of genital infections other than human papillomavirus with pre-invasive and invasive cervical neoplasia","volume":"10","author":"Mandal","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"issue":"4 e 1","key":"10.1016\/j.prp.2026.156591_bib40","first-page":"28","article-title":"Epidemiology and prevention of Human Papillomavirus","volume":"30","author":"Manini","year":"2018","journal-title":"Ann. Ig."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib41","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2213603","article-title":"Human papillomavirus vaccination at the first opportunity: an overview","volume":"19","author":"Bednarczyk","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.prp.2026.156591_bib42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-3-319-43139-0_3","article-title":"Pathology of endometrial carcinoma","volume":"943","author":"Lax","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"10.1016\/j.prp.2026.156591_bib43","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/his.12581","article-title":"Targeted mutation analysis of endometrial clear cell carcinoma","volume":"66","author":"Hoang","year":"2015","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib44","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ygyno.2015.09.001","article-title":"Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers","volume":"139","author":"Altman","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib45","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/his.12286","article-title":"Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1beta and oestrogen receptor","volume":"64","author":"Hoang","year":"2014","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.prp.2026.156591_bib46","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/PAS.0000000000000327","article-title":"Grading uterine endometrioid carcinoma: a proposal that binary is best","volume":"38","author":"Conlon","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"issue":"9","key":"10.1016\/j.prp.2026.156591_bib47","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/00000478-200009000-00002","article-title":"A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis","volume":"24","author":"Lax","year":"2000","journal-title":"Am. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2026.156591_bib48","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.bjc.6603012","article-title":"Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers","volume":"94","author":"Hamilton","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib49","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/IGC.0000000000000402","article-title":"Endometrial cancers in mutation carriers from hereditary breast ovarian cancer syndrome kindreds: report from the Creighton University Hereditary Cancer Registry with review of the implications","volume":"25","author":"Casey","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.prp.2026.156591_bib50","doi-asserted-by":"crossref","DOI":"10.1177\/11769351221076062","article-title":"Liquid biopsy: a distinctive approach to the diagnosis and prognosis of cancer","volume":"21","author":"Hirahata","year":"2022","journal-title":"Cancer Inform."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12943-022-01556-2","article-title":"Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer","volume":"21","author":"Zhou","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-022-01543-7","article-title":"Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments","volume":"21","author":"Lone","year":"2022","journal-title":"Mol. Cancer"},{"issue":"6378","key":"10.1016\/j.prp.2026.156591_bib53","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib54","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/cas.16097","article-title":"Beyond blood: advancing the frontiers of liquid biopsy in oncology and personalized medicine","volume":"115","author":"Bao","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.prp.2026.156591_bib55","first-page":"146","article-title":"A case of cancer in which cells similar to those in the tumours were seen in the blood after death","volume":"14","author":"Ashworth","year":"1869","journal-title":"Aust. Med. J."},{"key":"10.1016\/j.prp.2026.156591_bib56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/bs.acc.2017.10.003","article-title":"Liquid biopsy: from basic research to clinical practice","volume":"83","author":"Macias","year":"2018","journal-title":"Adv. Clin. Chem."},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib57","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.tips.2019.01.006","article-title":"Liquid biopsies in cancer diagnosis, monitoring, and prognosis","volume":"40","author":"De Rubis","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib58","first-page":"1395","article-title":"Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review)","volume":"53","author":"Finotti","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"11","key":"10.1016\/j.prp.2026.156591_bib59","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1039\/C9LC00274J","article-title":"Liquid biopsy using the nanotube-CTC-chip: capture of invasive CTCs with high purity using preferential adherence in breast cancer patients","volume":"19","author":"Loeian","year":"2019","journal-title":"Lab. Chip"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib60","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ygyno.2008.09.021","article-title":"Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer","volume":"112","author":"Fan","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.prp.2026.156591_bib61","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3390\/biom11070956","article-title":"Functional implications of the dynamic regulation of EpCAM during epithelial-to-mesenchymal transition","volume":"11","author":"Brown","year":"2021","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib62","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1002\/jcp.29252","article-title":"Hypoxia modulates stem cell properties and induces EMT through N-glycosylation of EpCAM in breast cancer cells","volume":"235","author":"Zhang","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib63","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12967-023-03960-8","article-title":"Liquid biopsies: the future of cancer early detection","volume":"21","author":"Connal","year":"2023","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib64","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/cyt.12661","article-title":"Liquid biopsy: a new avenue in pathology","volume":"30","author":"Ghosh","year":"2019","journal-title":"Cytopathology"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib65","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1038\/s41598-019-40241-1","article-title":"Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells","volume":"9","author":"Lian","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib66","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/cancers12020376","article-title":"Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer","volume":"12","author":"Papadaki","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3-4","key":"10.1016\/j.prp.2026.156591_bib67","first-page":"241","article-title":"Nuclear acids in human blood plasma","volume":"142","author":"Mandel","year":"1948","journal-title":"C. R. Seances Soc. Biol. Fil."},{"issue":"5","key":"10.1016\/j.prp.2026.156591_bib68","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.molmed.2020.12.011","article-title":"Liquid biopsy of methylation biomarkers in cell-free DNA","volume":"27","author":"Luo","year":"2021","journal-title":"Trends Mol. Med."},{"issue":"224","key":"10.1016\/j.prp.2026.156591_bib69","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.prp.2026.156591_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107458","article-title":"Circulating tumor DNA as an early cancer detection tool","volume":"207","author":"Campos-Carrillo","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.prp.2026.156591_bib71","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","article-title":"Integrating liquid biopsies into the management of cancer","volume":"14","author":"Siravegna","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.prp.2026.156591_bib72","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrclinonc.2013.110","article-title":"Liquid biopsy: monitoring cancer-genetics in the blood","volume":"10","author":"Crowley","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2026.156591_bib73","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/2159-8290.CD-13-1014","article-title":"Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA","volume":"4","author":"Haber","year":"2014","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.prp.2026.156591_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006162","article-title":"Fragment Length of circulating tumor DNA","volume":"12","author":"Underhill","year":"2016","journal-title":"PLoS. Genet."},{"issue":"466","key":"10.1016\/j.prp.2026.156591_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat4921","article-title":"Enhanced detection of circulating tumor DNA by fragment size analysis","volume":"10","author":"Mouliere","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.prp.2026.156591_bib76","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1373\/clinchem.2016.260331","article-title":"Circulating Tumor DNA as a cancer biomarker: fact or fiction?","volume":"62","author":"Leung","year":"2016","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.prp.2026.156591_bib77","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/cdd.2015.164","article-title":"Factor H uptake regulates intracellular C3 activation during apoptosis and decreases the inflammatory potential of nucleosomes","volume":"23","author":"Martin","year":"2016","journal-title":"Cell. Death Differ."},{"issue":"8","key":"10.1016\/j.prp.2026.156591_bib78","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1373\/clinchem.2013.203679","article-title":"High-resolution profiling of fetal DNA clearance from maternal plasma by massively parallel sequencing","volume":"59","author":"Yu","year":"2013","journal-title":"Clin. Chem."},{"issue":"403","key":"10.1016\/j.prp.2026.156591_bib79","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan2415","article-title":"Direct detection of early-stage cancers using circulating tumor DNA","volume":"9","author":"Phallen","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"167","key":"10.1016\/j.prp.2026.156591_bib80","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004952","article-title":"Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers","volume":"5","author":"Kinde","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"433","key":"10.1016\/j.prp.2026.156591_bib81","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap8793","article-title":"Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers","volume":"10","author":"Wang","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.prp.2026.156591_bib82","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/AOG.0000000000000484","article-title":"Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancer","volume":"124","author":"Erickson","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.prp.2026.156591_bib83","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12957-015-0732-1","article-title":"Role of peritoneal washing cytology in ovarian malignancies: correlation with histopathological parameters","volume":"13","author":"Naz","year":"2015","journal-title":"World J. Surg. Oncol."},{"issue":"3 Pt 1","key":"10.1016\/j.prp.2026.156591_bib84","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ajog.2005.01.054","article-title":"Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer","volume":"193","author":"Swisher","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"22","key":"10.1016\/j.prp.2026.156591_bib85","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1182\/blood-2018-12-852830","article-title":"Tumor-educated platelets","volume":"133","author":"In 't Veld S","year":"2019","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.prp.2026.156591_bib86","article-title":"Tumor-Educated Platelet RNA for the Detection and (Pseudo)progression Monitoring of Glioblastoma","volume":"1","author":"Sol","year":"2020","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.prp.2026.156591_bib87","article-title":"Tumor-educated platelets as a promising biomarker for blood-based detection of renal cell carcinoma","volume":"12","author":"Xiao","year":"2022","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib88","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccell.2017.07.004","article-title":"Swarm intelligence-enhanced detection of non-small-cell lung cancer using tumor-educated platelets","volume":"32","author":"Best","year":"2017","journal-title":"Cancer Cell."},{"issue":"5","key":"10.1016\/j.prp.2026.156591_bib89","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ccell.2015.09.018","article-title":"RNA-Seq of Tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics","volume":"28","author":"Best","year":"2015","journal-title":"Cancer Cell."},{"issue":"7","key":"10.1016\/j.prp.2026.156591_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070727","article-title":"Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis","volume":"8","author":"Doyle","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib91","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41416-021-01610-8","article-title":"Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research","volume":"126","author":"Ramirez-Garrastacho","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib92","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12943-019-0985-3","article-title":"The role of extracellular vesicles from different origin in the microenvironment of head and neck cancers","volume":"18","author":"Xie","year":"2019","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib93","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1515\/jtim-2025-0019","article-title":"Harnessing the potential of small extracellular vesicle biomarkers for cancer diagnosis and prognosis with advanced analytical technologies","volume":"13","author":"Tam","year":"2025","journal-title":"J. Transl. Int. Med."},{"key":"10.1016\/j.prp.2026.156591_bib94","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s43856-022-00088-6","article-title":"Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test","volume":"2","author":"Hinestrosa","year":"2022","journal-title":"Commun. Med. (Lond. )"},{"issue":"6","key":"10.1016\/j.prp.2026.156591_bib95","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"9","key":"10.1016\/j.prp.2026.156591_bib96","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/cbin.10301","article-title":"Long non-coding RNAs with low expression levels in cells are enriched in secreted exosomes","volume":"38","author":"Gezer","year":"2014","journal-title":"Cell. Biol. Int."},{"issue":"10","key":"10.1016\/j.prp.2026.156591_bib97","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/CIRCRESAHA.114.303915","article-title":"Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure","volume":"114","author":"Kumarswamy","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.prp.2026.156591_bib98","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"12","key":"10.1016\/j.prp.2026.156591_bib99","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/CIRCRESAHA.111.247452","article-title":"Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?","volume":"110","author":"Creemers","year":"2012","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib101","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/1940-6207.CAPR-11-0370","article-title":"Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies","volume":"5","author":"Pritchard","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib102","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MS9.0000000000002761","article-title":"Circular RNAs: history, metabolism, mechanisms of function, and regulatory roles at a glance","volume":"87","author":"Karimi","year":"2025","journal-title":"Ann. Med. Surg. (Lond. )"},{"issue":"5","key":"10.1016\/j.prp.2026.156591_bib103","article-title":"Back to the Origin: Mechanisms of circRNA-Directed Regulation of Host Genes in Human Disease","volume":"10","author":"Yuan","year":"2024","journal-title":"Noncoding RNA"},{"issue":"21","key":"10.1016\/j.prp.2026.156591_bib104","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1038\/emboj.2011.359","article-title":"miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA","volume":"30","author":"Hansen","year":"2011","journal-title":"EMBO J."},{"issue":"7441","key":"10.1016\/j.prp.2026.156591_bib105","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.prp.2026.156591_bib106","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12575-020-00122-8","article-title":"Deep Insights in Circular RNAs: from biogenesis to therapeutics","volume":"22","author":"Mumtaz","year":"2020","journal-title":"Biol. Proced. Online"},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib107","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","article-title":"The emerging roles of circRNAs in cancer and oncology","volume":"19","author":"Kristensen","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.prp.2026.156591_bib108","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/jnr.25094","article-title":"Novel insights into the role of circular RNAs in Parkinson disease: An emerging renaissance in the management of neurodegenerative diseases","volume":"100","author":"Dorostgou","year":"2022","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.prp.2026.156591_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104263","article-title":"The role of liquid biopsy in epithelial ovarian cancer: State of the art","volume":"194","author":"Della Corte","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"5","key":"10.1016\/j.prp.2026.156591_bib110","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1159\/000492521","article-title":"Analysis of circulating tumor cells in ovarian cancer and their clinical value as a biomarker","volume":"48","author":"Zhang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"7","key":"10.1016\/j.prp.2026.156591_bib111","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.18632\/oncotarget.23943","article-title":"Diagnostic value of HE4+ circulating tumor cells in patients with suspicious ovarian cancer","volume":"9","author":"Guo","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib112","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2012.09.021","article-title":"Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortium","volume":"128","author":"Obermayr","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib113","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ygyno.2014.06.013","article-title":"Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer","volume":"134","author":"Pearl","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib114","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2015.03.002","article-title":"Treatment monitoring of patients with epithelial ovarian cancer using invasive circulating tumor cells (iCTCs)","volume":"137","author":"Pearl","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib115","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ygyno.2017.02.042","article-title":"Predictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancer","volume":"145","author":"Lee","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.prp.2026.156591_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070732","article-title":"Detection of abundant non-haematopoietic circulating cancer-related cells in patients with advanced epithelial ovarian cancer","volume":"8","author":"Kumar","year":"2019","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib117","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ygyno.2021.02.024","article-title":"Enrichment and detection method for the prognostic value of circulating tumor cells in ovarian cancer: a meta-analysis","volume":"161","author":"Huang","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.prp.2026.156591_bib118","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.celrep.2018.01.053","article-title":"Commonly occurring cell subsets in high-grade serous ovarian tumors identified by single-cell mass cytometry","volume":"22","author":"Gonzalez","year":"2018","journal-title":"Cell. Rep."},{"issue":"10","key":"10.1016\/j.prp.2026.156591_bib119","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1373\/clinchem.2014.224808","article-title":"ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum resistance","volume":"60","author":"Kuhlmann","year":"2014","journal-title":"Clin. Chem."},{"issue":"63","key":"10.1016\/j.prp.2026.156591_bib120","doi-asserted-by":"crossref","first-page":"106415","DOI":"10.18632\/oncotarget.22468","article-title":"Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium","volume":"8","author":"Obermayr","year":"2017","journal-title":"Oncotarget"},{"issue":"30","key":"10.1016\/j.prp.2026.156591_bib121","doi-asserted-by":"crossref","first-page":"48820","DOI":"10.18632\/oncotarget.16179","article-title":"EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy","volume":"8","author":"Chebouti","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib122","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.1038\/s41598-021-86122-4","article-title":"Development and validation for prognostic nomogram of epithelial ovarian cancer recurrence based on circulating tumor cells and epithelial-mesenchymal transition","volume":"11","author":"Yang","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib123","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ygyno.2011.05.028","article-title":"Circulating tumor cells predict progression free survival and overall survival in patients with relapsed\/recurrent advanced ovarian cancer","volume":"122","author":"Poveda","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"20","key":"10.1016\/j.prp.2026.156591_bib124","article-title":"Post-debulking circulating tumor cell as a poor prognostic marker in advanced stage ovarian cancer: a prospective observational study","volume":"98","author":"Kim","year":"2019","journal-title":"Med. (Baltim. )"},{"issue":"11","key":"10.1016\/j.prp.2026.156591_bib125","first-page":"3363","article-title":"The added value of circulating tumor cells examination in ovarian cancer staging","volume":"5","author":"Kolostova","year":"2015","journal-title":"Am. J. Cancer Res."},{"issue":"15","key":"10.1016\/j.prp.2026.156591_bib126","doi-asserted-by":"crossref","first-page":"24303","DOI":"10.18632\/oncotarget.13286","article-title":"ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer","volume":"8","author":"Chebouti","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib127","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/(SICI)1097-0215(19970220)74:1<75::AID-IJC13>3.0.CO;2-H","article-title":"Detection of squamous-cell carcinoma antigen-expressing tumour cells in blood by reverse transcriptase-polymerase chain reaction in cancer of the uterine cervix","volume":"74","author":"Stenman","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2026.156591_bib128","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1038\/srep03970","article-title":"Digital-Direct-RT-PCR: a sensitive and specific method for quantification of CTC in patients with cervical carcinoma","volume":"4","author":"Pfitzner","year":"2014","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.prp.2026.156591_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204334","article-title":"Elevated circulating tumor cells and squamous cell carcinoma antigen levels predict poor survival for patients with locally advanced cervical cancer treated with radiotherapy","volume":"13","author":"Wen","year":"2018","journal-title":"PLoS. One"},{"key":"10.1016\/j.prp.2026.156591_bib130","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.2147\/CMAR.S198391","article-title":"Distribution of circulating tumor cell phenotype in early cervical cancer","volume":"11","author":"Pan","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"11","key":"10.1016\/j.prp.2026.156591_bib131","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1158\/1535-7163.MCT-20-0276","article-title":"Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062)","volume":"19","author":"Tewari","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.prp.2026.156591_bib132","doi-asserted-by":"crossref","DOI":"10.1177\/1533033820957005","article-title":"Circulating tumor cells counting act as a potential prognostic factor in cervical cancer","volume":"19","author":"Du","year":"2020","journal-title":"Technol. Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.prp.2026.156591_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060774","article-title":"Liquid biopsies for ovarian carcinoma: how blood tests may improve the clinical management of a deadly disease","volume":"11","author":"Mari","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156591_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.143993","article-title":"Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: an updated meta-analysis","volume":"714","author":"Li","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.prp.2026.156591_bib135","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2018.5","article-title":"Potential clinical applications of circulating cell-free DNA in ovarian cancer patients","volume":"20","author":"Barbosa","year":"2018","journal-title":"Expert. Rev. Mol. Med."},{"issue":"36","key":"10.1016\/j.prp.2026.156591_bib136","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2015.61.3083","article-title":"Lavage of the uterine cavity for molecular detection of mullerian duct carcinomas: a proof-of-concept study","volume":"33","author":"Maritschnegg","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib137","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ygyno.2013.04.048","article-title":"A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA","volume":"130","author":"Zhang","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib138","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3892\/ol.2017.6111","article-title":"Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer","volume":"14","author":"Wang","year":"2017","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib139","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/147323001204000231","article-title":"Frequent SLIT2 promoter methylation in the serum of patients with ovarian cancer","volume":"40","author":"Dong","year":"2012","journal-title":"J. Int. Med. Res."},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib140","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.7314\/APJCP.2014.15.3.1171","article-title":"Aberrant methylation of RASSF2A in tumors and plasma of patients with epithelial ovarian cancer","volume":"15","author":"Wu","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib141","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ygyno.2010.09.019","article-title":"Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors","volume":"120","author":"Liggett","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib142","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ygyno.2011.08.029","article-title":"Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancer","volume":"123","author":"Bondurant","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.prp.2026.156591_bib143","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002198","article-title":"Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study","volume":"13","author":"Parkinson","year":"2016","journal-title":"PLoS. Med."},{"issue":"136","key":"10.1016\/j.prp.2026.156591_bib144","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003726","article-title":"Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA","volume":"4","author":"Forshew","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12916-016-0667-6","article-title":"Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening","volume":"14","author":"Cohen","year":"2016","journal-title":"BMC Med."},{"issue":"6","key":"10.1016\/j.prp.2026.156591_bib146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155495","article-title":"Circulating Cell Free DNA as the diagnostic marker for ovarian cancer: a systematic review and meta-analysis","volume":"11","author":"Zhou","year":"2016","journal-title":"PLoS. One"},{"issue":"6","key":"10.1016\/j.prp.2026.156591_bib147","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.3892\/ol.2015.3771","article-title":"Quantitative analysis of cell-free DNA in ovarian cancer","volume":"10","author":"Shao","year":"2015","journal-title":"Oncol. Lett."},{"issue":"9","key":"10.1016\/j.prp.2026.156591_bib148","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1158\/1078-0432.CCR-16-1078","article-title":"Chromosomal Instability in Cell-Free DNA as a highly specific biomarker for detection of ovarian cancer in women with adnexal masses","volume":"23","author":"Vanderstichele","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.prp.2026.156591_bib149","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113382","article-title":"Comprehensive Gene Mutation Profiling of Circulating Tumor DNA in Ovarian Cancer: Its Pathological and Prognostic Impact","volume":"12","author":"Noguchi","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13148-023-01440-w","article-title":"Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review","volume":"15","author":"Terp","year":"2023","journal-title":"Clin. Epigenetics"},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib151","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ygyno.2018.05.026","article-title":"ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer","volume":"150","author":"Giannopoulou","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.prp.2026.156591_bib152","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejca.2019.11.012","article-title":"Circulating HOXA9-methylated tumour DNA: A novel biomarker of response to poly (ADP-ribose) polymerase inhibition in BRCA-mutated epithelial ovarian cancer","volume":"125","author":"Rusan","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.prp.2026.156591_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.bj.2022.09.004","article-title":"Mutations in circulating tumor DNA detected in the postoperative period predict poor survival in patients with ovarian cancer","volume":"46","author":"Chao","year":"2023","journal-title":"Biomed. J."},{"key":"10.1016\/j.prp.2026.156591_bib154","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.946257","article-title":"Whole-genome\/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trial","volume":"12","author":"Sabatier","year":"2022","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100520","article-title":"Serum exosomes from epithelial ovarian cancer patients contain lrp1, which promotes the migration of epithelial ovarian cancer cell","volume":"22","author":"Zhou","year":"2023","journal-title":"Mol. Cell. Proteom."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib156","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.canlet.2015.07.014","article-title":"Exosomes: Emerging biomarkers and targets for ovarian cancer","volume":"367","author":"Tang","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2026.156591_bib157","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/1471-2407-9-244","article-title":"Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer","volume":"9","author":"Li","year":"2009","journal-title":"BMC Cancer"},{"issue":"13","key":"10.1016\/j.prp.2026.156591_bib158","doi-asserted-by":"crossref","first-page":"16923","DOI":"10.18632\/oncotarget.7850","article-title":"Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer","volume":"7","author":"Meng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2026.156591_bib159","first-page":"3","article-title":"Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy","volume":"4","author":"Szajnik","year":"2013","journal-title":"Gynecol. Obstet. (Sunnyvale)"},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib160","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ygyno.2007.08.064","article-title":"Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM","volume":"107","author":"Runz","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2026.156591_bib161","first-page":"1719","article-title":"Proteomics profiling of plasma exosomes in epithelial ovarian cancer: A potential role in the coagulation cascade, diagnosis and prognosis","volume":"54","author":"Zhang","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"8","key":"10.1016\/j.prp.2026.156591_bib162","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081106","article-title":"Vesicular-Bound HLA-G as a predictive marker for disease progression in epithelial ovarian cancer","volume":"11","author":"Schwich","year":"2019","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.prp.2026.156591_bib163","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1158\/1535-7163.MCT-05-0102","article-title":"Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells","volume":"4","author":"Safaei","year":"2005","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib164","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2014.12.042","article-title":"The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells","volume":"137","author":"Pink","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2026.156591_bib165","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/cam4.409","article-title":"Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells","volume":"4","author":"Weiner-Gorzel","year":"2015","journal-title":"Cancer Med."},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib166","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/jcp.22773","article-title":"Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy","volume":"227","author":"Ciravolo","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.prp.2026.156591_bib167","article-title":"A Combined Long Noncoding RNA signature as a candidate prognostic biomarker for ovarian cancer","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib168","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41419-020-03358-0","article-title":"Inhibition of long non-coding RNA XIST upregulates microRNA-149-3p to repress ovarian cancer cell progression","volume":"12","author":"Jiang","year":"2021","journal-title":"Cell. Death Dis."},{"issue":"6","key":"10.1016\/j.prp.2026.156591_bib169","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1007\/s13277-015-3138-3","article-title":"MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer","volume":"36","author":"Gao","year":"2015","journal-title":"Tumour Biol."},{"issue":"9","key":"10.1016\/j.prp.2026.156591_bib170","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.7150\/jca.30231","article-title":"Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas","volume":"10","author":"Kim","year":"2019","journal-title":"J. Cancer"},{"issue":"6","key":"10.1016\/j.prp.2026.156591_bib171","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.3892\/or.2015.3937","article-title":"Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma","volume":"33","author":"Zhou","year":"2015","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib172","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s12253-015-9914-y","article-title":"Evaluation of Cell-Free Urine microRNAs expression for the use in diagnosis of ovarian and endometrial cancers. a pilot study","volume":"21","author":"Zavesky","year":"2015","journal-title":"Pathol. Oncol. Res."},{"issue":"8","key":"10.1016\/j.prp.2026.156591_bib173","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23893","article-title":"miR-92a promotes cervical cancer cell proliferation, invasion, and migration by directly targeting PIK3R1","volume":"35","author":"Wang","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib174","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.gendis.2021.02.002","article-title":"miR-106b as an emerging therapeutic target in cancer","volume":"9","author":"Sagar","year":"2022","journal-title":"Genes. Dis."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib175","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00404-021-06287-1","article-title":"Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case-control study","volume":"306","author":"Berner","year":"2022","journal-title":"Arch. Gynecol. Obstet."},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib176","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1200\/JCO.1997.15.3.1008","article-title":"Detection of human papillomavirus mRNA and cervical cancer cells in peripheral blood of cervical cancer patients with metastasis","volume":"15","author":"Pao","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib177","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1006\/gyno.2002.6587","article-title":"Detecting cytokeratin 19 mRNA in the peripheral blood cells of cervical cancer patients and its clinical-pathological correlation","volume":"85","author":"Yuan","year":"2002","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.prp.2026.156591_bib178","first-page":"1203","article-title":"Isolation, primary culture, morphological and molecular characterization of circulating tumor cells in gynecological cancers","volume":"7","author":"Kolostova","year":"2015","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib179","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/cas.13449","article-title":"Detection of circulating tumor cells in cervical cancer using a conditionally replicative adenovirus targeting telomerase-positive cells","volume":"109","author":"Takakura","year":"2018","journal-title":"Cancer Sci."},{"issue":"22","key":"10.1016\/j.prp.2026.156591_bib180","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1158\/1078-0432.CCR-17-1553","article-title":"Circulating Cell-free DNA for metastatic cervical cancer detection, genotyping, and monitoring","volume":"23","author":"Kang","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib181","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ygyno.2017.05.038","article-title":"Liquid biopsy of PIK3CA mutations in cervical cancer in Hong Kong Chinese women","volume":"146","author":"Chung","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib182","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ijc.33362","article-title":"Dynamic analysis of circulating tumor DNA to predict prognosis and monitor therapeutic response in metastatic relapsed cervical cancer","volume":"148","author":"Tian","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib183","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41467-020-20162-8","article-title":"Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"issue":"7645","key":"10.1016\/j.prp.2026.156591_bib184","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature21386","article-title":"Network CGAR. Integrated genomic and molecular characterization of cervical cancer","volume":"543","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib185","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/1878-0261.12791","article-title":"Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients","volume":"15","author":"Charo","year":"2021","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib186","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1186\/s12885-020-07161-0","article-title":"Efficient mutation screening for cervical cancers from circulating tumor DNA in blood","volume":"20","author":"Lee","year":"2020","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.prp.2026.156591_bib187","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1158\/1940-6207.CAPR-16-0138","article-title":"Molecular triage of premalignant lesions in liquid-based cervical cytology and circulating cell-free DNA from urine, using a panel of methylated human papilloma virus and host genes","volume":"9","author":"Guerrero-Preston","year":"2016","journal-title":"Cancer Prev Res (Phila)"},{"issue":"7","key":"10.1016\/j.prp.2026.156591_bib188","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/cbf.3307","article-title":"ATF1 and RAS in exosomes are potential clinical diagnostic markers for cervical cancer","volume":"35","author":"Shi","year":"2017","journal-title":"Cell. Biochem. Funct."},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib189","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41389-021-00319-w","article-title":"Tumor-secreted exosomal Wnt2B activates fibroblasts to promote cervical cancer progression","volume":"10","author":"Liang","year":"2021","journal-title":"Oncogenesis"},{"issue":"7","key":"10.1016\/j.prp.2026.156591_bib190","first-page":"2474","article-title":"The exosome-mediated PI3k\/Akt\/mTOR signaling pathway in cervical cancer","volume":"12","author":"Zhang","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib191","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12935-021-02026-3","article-title":"Exosomes from cervical cancer cells facilitate pro-angiogenic endothelial reconditioning through transfer of Hedgehog-GLI signaling components","volume":"21","author":"Bhat","year":"2021","journal-title":"Cancer Cell. Int."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib192","first-page":"523","article-title":"MicroRNA expressions in HPV-induced cervical dysplasia and cancer","volume":"35","author":"Gocze","year":"2015","journal-title":"Anticancer. Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib193","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.febslet.2013.11.019","article-title":"miR-181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 (AC9) in cervical cancer cells","volume":"588","author":"Yang","year":"2014","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib194","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.3892\/mmr.2017.7143","article-title":"MicroRNA-21 regulates the proliferation and apoptosis of cervical cancer cells via tumor necrosis factor-alpha","volume":"16","author":"Xu","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/2211536609666191115110015","article-title":"miR-21 and miR29-a: Potential Molecular Biomarkers for HPV Genotypes and Cervical Cancer Detection","volume":"9","author":"Zamani","year":"2020","journal-title":"Microrna"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib196","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12885-019-5620-6","article-title":"microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer","volume":"19","author":"Park","year":"2019","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.prp.2026.156591_bib197","first-page":"1740","article-title":"Down-regulation of miR-664 in cervical cancer is associated with lower overall survival","volume":"20","author":"Zhang","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib198","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3233\/CBM-190256","article-title":"Circulating plasma microRNA signature for the diagnosis of cervical cancer","volume":"26","author":"Ma","year":"2019","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.prp.2026.156591_bib199","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.2147\/OTT.S239979","article-title":"Interfering Human Papillomavirus E6\/E7 Oncogenes in cervical cancer cells inhibits the angiogenesis of vascular endothelial cells via increasing mir-377 in cervical cancer cell-derived microvesicles","volume":"13","author":"Zhang","year":"2020","journal-title":"Onco Targets Ther."},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004712","article-title":"Dependence of intracellular and exosomal microRNAs on viral E6\/E7 oncogene expression in HPV-positive tumor cells","volume":"11","author":"Honegger","year":"2015","journal-title":"PLoS. Pathog."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib201","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12943-019-0999-x","article-title":"Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors","volume":"18","author":"Zheng","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2026.156591_bib202","doi-asserted-by":"crossref","first-page":"10307","DOI":"10.2147\/CMAR.S221527","article-title":"Cervical Cancer Cells-Secreted Exosomal microRNA-221-3p promotes invasion, migration and angiogenesis of microvascular endothelial cells in cervical cancer by down-regulating MAPK10 Expression","volume":"11","author":"Zhang","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"9","key":"10.1016\/j.prp.2026.156591_bib203","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/1878-0261.12737","article-title":"The STAT3-miR-223-TGFBR3\/HMGCS1 axis modulates the progression of cervical carcinoma","volume":"14","author":"Zhang","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.prp.2026.156591_bib204","doi-asserted-by":"crossref","DOI":"10.1177\/1533033821990060","article-title":"Serum Exosomal lncRNA DLX6-AS1 Is a promising biomarker for prognosis prediction of cervical cancer","volume":"20","author":"Ding","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib205","first-page":"129","article-title":"Long Noncoding RNA DLX6-AS1 promotes the progression in cervical cancer by targeting miR-16-5p\/ARPP19 Axis","volume":"35","author":"Xie","year":"2020","journal-title":"Cancer Biother Radiopharm."},{"issue":"15","key":"10.1016\/j.prp.2026.156591_bib206","doi-asserted-by":"crossref","first-page":"19230","DOI":"10.18632\/aging.202565","article-title":"LncRNA LINC01305 promotes cervical cancer progression through KHSRP and exosome-mediated transfer","volume":"13","author":"Huang","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"10.1016\/j.prp.2026.156591_bib207","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12823","article-title":"LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression","volume":"53","author":"Xu","year":"2020","journal-title":"Cell. Prolif."},{"issue":"6","key":"10.1016\/j.prp.2026.156591_bib208","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/jcla.21990","article-title":"Exosomal Long Noncoding RNAs are Differentially Expressed in the Cervicovaginal Lavage Samples of Cervical Cancer Patients","volume":"30","author":"Zhang","year":"2016","journal-title":"J. Clin. Lab. Anal."},{"issue":"20","key":"10.1016\/j.prp.2026.156591_bib209","doi-asserted-by":"crossref","first-page":"20139","DOI":"10.18632\/aging.103679","article-title":"Circular RNA circ_PVT1 induces epithelial-mesenchymal transition to promote metastasis of cervical cancer","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib210","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.7963","article-title":"Exosomal miR\u2011663b exposed to TGF\u2011beta1 promotes cervical cancer metastasis and epithelial\u2011mesenchymal transition by targeting MGAT3","volume":"45","author":"You","year":"2021","journal-title":"Oncol. Rep."},{"issue":"17","key":"10.1016\/j.prp.2026.156591_bib211","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.2217\/nnm-2018-0143","article-title":"Upstream Hedgehog signaling components are exported in exosomes of cervical cancer cell lines","volume":"13","author":"Bhat","year":"2018","journal-title":"Nanomedicine"},{"issue":"13","key":"10.1016\/j.prp.2026.156591_bib212","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1158\/0008-5472.CAN-06-0561","article-title":"Patterns of known and novel small RNAs in human cervical cancer","volume":"67","author":"Lui","year":"2007","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.prp.2026.156591_bib213","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1089\/gtmb.2013.0085","article-title":"Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer","volume":"17","author":"Zhao","year":"2013","journal-title":"Genet. Test. Mol. Biomark."},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib214","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3892\/mco.2015.560","article-title":"Expression profile of circulating microRNAs as a promising fingerprint for cervical cancer diagnosis and monitoring","volume":"3","author":"Jia","year":"2015","journal-title":"Mol. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib215","doi-asserted-by":"crossref","first-page":"9033","DOI":"10.1038\/s41598-020-65850-z","article-title":"Applying Serum Proteins and MicroRNA as Novel Biomarkers for Early-Stage Cervical Cancer Detection","volume":"10","author":"Du","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib216","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00432-012-1147-9","article-title":"Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion","volume":"138","author":"Yu","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib217","first-page":"1389","article-title":"Heterogeneity of microRNAs expression in cervical cancer cells: over-expression of miR-196a","volume":"7","author":"Villegas-Ruiz","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib218","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.bbrc.2013.09.142","article-title":"miR-196a targets netrin 4 and regulates cell proliferation and migration of cervical cancer cells","volume":"440","author":"Zhang","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib219","doi-asserted-by":"crossref","first-page":"17995","DOI":"10.4238\/2015.December.22.25","article-title":"Clinical significance of serum miR-196a in cervical intraepithelial neoplasia and cervical cancer","volume":"14","author":"Liu","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib220","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3892\/ijmm.2013.1424","article-title":"Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma","volume":"32","author":"Chen","year":"2013","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib221","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/0004563216649377","article-title":"MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer","volume":"54","author":"Sun","year":"2017","journal-title":"Ann. Clin. Biochem."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib222","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ygyno.2019.08.012","article-title":"Enumeration of deregulated miRNAs in liquid and tissue biopsies of cervical cancer","volume":"155","author":"Shukla","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib223","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12885-017-3753-z","article-title":"Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms","volume":"18","author":"Li","year":"2018","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.prp.2026.156591_bib224","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.3892\/ol.2016.5038","article-title":"MicroRNA-138 inhibits proliferation, migration and invasion through targeting hTERT in cervical cancer","volume":"12","author":"Zhou","year":"2016","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.prp.2026.156591_bib225","first-page":"3541","article-title":"MiR-214 inhibits cell migration, invasion and promotes the drug sensitivity in human cervical cancer by targeting FOXM1","volume":"9","author":"Wang","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib226","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ygyno.2017.01.018","article-title":"MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene","volume":"145","author":"Li","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib227","first-page":"1","article-title":"HOTAIR: an oncogenic long non-coding RNA in different cancers","volume":"12","author":"Hajjari","year":"2015","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.prp.2026.156591_bib228","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cbi.2018.03.010","article-title":"Long non-coding RNA HOTAIR and STAT3 synergistically regulate the cervical cancer cell migration and invasion","volume":"286","author":"Zhang","year":"2018","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"10.1016\/j.prp.2026.156591_bib229","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1159\/000487595","article-title":"Four Circulating Long Non-Coding RNAs Act as Biomarkers for Predicting Cervical Cancer","volume":"83","author":"Sun","year":"2018","journal-title":"Gynecol. Obstet. Invest."},{"issue":"11","key":"10.1016\/j.prp.2026.156591_bib230","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/2211-5463.12523","article-title":"Identification of reference genes for circulating long noncoding RNA analysis in serum of cervical cancer patients","volume":"8","author":"Iempridee","year":"2018","journal-title":"FEBS Open. Bio"},{"key":"10.1016\/j.prp.2026.156591_bib231","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2016.09.031","article-title":"Detection of circulating tumour cells may add value in endometrial cancer management","volume":"207","author":"Ni","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib232","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000445999","article-title":"Enumeration and molecular characterisation of circulating tumour cells in endometrial cancer","volume":"91","author":"Lemech","year":"2016","journal-title":"Oncology"},{"key":"10.1016\/j.prp.2026.156591_bib233","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1186\/1471-2407-10-666","article-title":"Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients","volume":"10","author":"Obermayr","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2026.156591_bib234","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/1476-4598-13-223","article-title":"Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer","volume":"13","author":"Alonso-Alconada","year":"2014","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.prp.2026.156591_bib235","first-page":"1491","article-title":"Value of circulating tumor cells positive for thyroid transcription factor-1 (TTF-1) to predict recurrence and survival rates for endometrial carcinoma","volume":"21","author":"Zhang","year":"2016","journal-title":"J. BUON"},{"issue":"6 16","key":"10.1016\/j.prp.2026.156591_bib236","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/sonc.2002.37263","article-title":"Role of angiogenesis in tumor growth and metastasis","volume":"29","author":"Folkman","year":"2002","journal-title":"Semin. Oncol."},{"issue":"11","key":"10.1016\/j.prp.2026.156591_bib237","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s00432-017-2474-7","article-title":"Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma","volume":"143","author":"Kommoss","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2026.156591_bib238","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/IGC.0b013e3181a23c4c","article-title":"Disseminated tumor cells in bone marrow may affect prognosis of patients with gynecologic malignancies","volume":"19","author":"Banys","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib239","first-page":"683","article-title":"Detection of circulating tumor cells in high-risk endometrial cancer","volume":"35","author":"Bogani","year":"2015","journal-title":"Anticancer. Res."},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib240","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/ijc.25077","article-title":"Circulating free DNA, p53 antibody and mutations of KRAS gene in endometrial cancer","volume":"127","author":"Dobrzycka","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib241","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/IGC.0b013e3182328c94","article-title":"Role of circulating free alu DNA in endometrial cancer","volume":"22","author":"Tanaka","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"70","key":"10.1016\/j.prp.2026.156591_bib242","doi-asserted-by":"crossref","first-page":"115230","DOI":"10.18632\/oncotarget.23247","article-title":"Circulating cell-free DNA content as blood based biomarker in endometrial cancer","volume":"8","author":"Cicchillitti","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib243","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jmoldx.2015.11.004","article-title":"Robust Detection of DNA Hypermethylation of ZNF154 as a Pan-Cancer Locus with in Silico Modeling for Blood-Based Diagnostic Development","volume":"18","author":"Margolin","year":"2016","journal-title":"J. Mol. Diagn."},{"issue":"12","key":"10.1016\/j.prp.2026.156591_bib244","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145754","article-title":"Personalized Circulating Tumor DNA biomarkers dynamically predict treatment response and survival in gynecologic cancers","volume":"10","author":"Pereira","year":"2015","journal-title":"PLoS. One"},{"issue":"22","key":"10.1016\/j.prp.2026.156591_bib245","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13225731","article-title":"Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer","volume":"13","author":"Lukasiewicz","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156591_bib246","article-title":"High-throughput, low-cost and rapid DNA sequencing using surface-coating techniques","volume":"2020","author":"Qin","year":"2020","journal-title":"BioRxiv"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib247","first-page":"19","article-title":"Relationship between Promoter Hypermethylation of DNMT3A and DNMT3B genes and Endometrial Cancer","volume":"1","author":"Omidali","year":"2019","journal-title":"J. Epigenetics"},{"key":"10.1016\/j.prp.2026.156591_bib248","article-title":"Metformin Regulates TET2 expression to inhibit endometrial carcinoma proliferation: a new mechanism","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2026.156591_bib249","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/1471-2407-12-369","article-title":"Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma","volume":"12","author":"Torres","year":"2012","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.prp.2026.156591_bib250","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/ijc.27840","article-title":"Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients","volume":"132","author":"Torres","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib251","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3892\/ol.2013.1338","article-title":"Identification of four serum microRNAs from a genome-wide serum microRNA expression profile as potential non-invasive biomarkers for endometrioid endometrial cancer","volume":"6","author":"Jia","year":"2013","journal-title":"Oncol. Lett."},{"issue":"42","key":"10.1016\/j.prp.2026.156591_bib252","doi-asserted-by":"crossref","first-page":"68894","DOI":"10.18632\/oncotarget.12028","article-title":"Diagnostic value of circulating miR-21: An update meta-analysis in various cancers and validation in endometrial cancer","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib253","doi-asserted-by":"crossref","DOI":"10.3390\/proteomes7020022","article-title":"Challenges in the isolation and proteomic analysis of cancer exosomes-implications for translational research","volume":"7","author":"Jablonska","year":"2019","journal-title":"Proteomes"},{"issue":"8","key":"10.1016\/j.prp.2026.156591_bib254","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/ijc.29213","article-title":"Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer","volume":"136","author":"Alonso-Alconada","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib255","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1186\/s12885-016-2631-4","article-title":"L1CAM as a prognostic marker in stage I endometrial cancer: a validation study","volume":"16","author":"Smogeli","year":"2016","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib256","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygyno.2016.02.003","article-title":"L1CAM is an independent predictor of poor survival in endometrial cancer\u2014an analysis of The Cancer Genome Atlas (TCGA)","volume":"141","author":"Dellinger","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"15","key":"10.1016\/j.prp.2026.156591_bib257","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.ejca.2014.07.014","article-title":"L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results","volume":"50","author":"Bosse","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib258","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/his.13405","article-title":"The significance of L1CAM expression in clear cell carcinoma of the endometrium","volume":"72","author":"Fadare","year":"2018","journal-title":"Histopathology"},{"issue":"35","key":"10.1016\/j.prp.2026.156591_bib259","doi-asserted-by":"crossref","first-page":"30911","DOI":"10.1074\/jbc.M111.271155","article-title":"Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexin A2","volume":"286","author":"Valapala","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1158\/1541-7786.MCR-16-0163","article-title":"Exosomal Annexin II promotes angiogenesis and breast cancer metastasis","volume":"15","author":"Maji","year":"2017","journal-title":"Mol. Cancer Res."},{"issue":"12","key":"10.1016\/j.prp.2026.156591_bib261","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11122000","article-title":"Extracellular vesicles-based biomarkers represent a promising liquid biopsy in endometrial cancer","volume":"11","author":"Herrero","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib262","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.gpb.2017.01.004","article-title":"eTumorType, An algorithm of discriminating cancer types for circulating tumor cells or cell-free DNAs in Blood","volume":"15","author":"Zou","year":"2017","journal-title":"Genom. Proteom. Bioinforma."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib263","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41392-020-0199-6","article-title":"Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence","volume":"5","author":"Wang","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.prp.2026.156591_bib264","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1194719","article-title":"Circular RNAs in gynecologic cancers: mechanisms and implications for chemotherapy resistance","volume":"14","author":"Qin","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.prp.2026.156591_bib265","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.diii.2018.11.007","article-title":"Ovarian cancer: An update on imaging in the era of radiomics","volume":"100","author":"Nougaret","year":"2019","journal-title":"Diagn. Interv. Imaging"},{"issue":"9","key":"10.1016\/j.prp.2026.156591_bib266","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12032-023-02128-0","article-title":"Liquid biopsy in ovarian cancer: advantages and limitations for prognosis and diagnosis","volume":"40","author":"Karimi","year":"2023","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib267","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13048-023-01129-x","article-title":"Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma","volume":"16","author":"Feng","year":"2023","journal-title":"J. Ovarian Res."},{"issue":"14","key":"10.1016\/j.prp.2026.156591_bib268","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.3390\/cancers15143642","article-title":"Mechanisms of PARP-Inhibitor-Resistance in BRCA-mutated breast cancer and new therapeutic approaches","volume":"15","author":"Dilmac","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156591_bib269","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-23-0797","article-title":"Identifying mechanisms of resistance by circulating tumour DNA in EVOLVE, a Phase II trial of cediranib plus olaparib for ovarian cancer at time of parp inhibitor progression","author":"Lheureux","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib270","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ygyno.2022.08.021","article-title":"Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma","volume":"167","author":"O'Malley","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"701","key":"10.1016\/j.prp.2026.156591_bib271","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add7872","article-title":"BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor\u2013resistant BRCA-mutant ovarian cancer","volume":"15","author":"Gupta","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.prp.2026.156591_bib272","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.3390\/cancers13102386","article-title":"Liquid biopsy in the clinical management of high-grade serous epithelial ovarian cancer-current use and future opportunities","volume":"13","author":"Paracchini","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2026.156591_bib273","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cancergen.2019.10.001","article-title":"Progress in quantitative technique of circulating cell free DNA and its role in cancer diagnosis and prognosis","volume":"239","author":"Weng","year":"2019","journal-title":"Cancer Genet."},{"key":"10.1016\/j.prp.2026.156591_bib274","unstructured":"Paterson E. Investigating extracellular vesicles as predictive biomarkers of LNG-IUD treatment response in early endometrial cancer: University of Otago; 2021."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib275","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s41232-021-00170-x","article-title":"Single-cell and spatial analyses of cancer cells: toward elucidating the molecular mechanisms of clonal evolution and drug resistance acquisition","volume":"41","author":"Nagasawa","year":"2021","journal-title":"Inflamm. Regen."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib276","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.21037\/atm.2018.11.31","article-title":"Liquid biopsy in tumors: opportunities and challenges","volume":"6","author":"Bai","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.prp.2026.156591_bib277","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.csbj.2018.05.002","article-title":"ctDNA and CTCs in liquid biopsy\u2013current status and where we need to progress","volume":"16","author":"Neumann","year":"2018","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.prp.2026.156591_bib278","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2019.09.001","article-title":"Epithelial keratins: biology and implications as diagnostic markers for liquid biopsies","volume":"72","author":"Werner","year":"2020","journal-title":"Mol. Asp. Med."},{"issue":"9","key":"10.1016\/j.prp.2026.156591_bib279","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","article-title":"Integrating liquid biopsies into the management of cancer","volume":"14","author":"Siravegna","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib280","article-title":"Recent advances and application of whole genome amplification in molecular diagnosis and medicine","volume":"3","author":"Wang","year":"2022","journal-title":"MedComm (2020)."},{"issue":"1","key":"10.1016\/j.prp.2026.156591_bib281","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34365-z","article-title":"Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes","volume":"8","author":"Soler","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.prp.2026.156591_bib282","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ijc.33217","article-title":"Liquid biopsies: Potential and challenges","volume":"148","author":"Heidrich","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2026.156591_bib283","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1158\/2159-8290.CD-20-1311","article-title":"Liquid biopsy: from discovery to clinical application","volume":"11","author":"Alix-Panabieres","year":"2021","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.prp.2026.156591_bib284","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150197","article-title":"Optimised pre-analytical methods improve KRAS mutation detection in circulating tumour DNA (ctDNA) from patients with non-small cell lung cancer (NSCLC)","volume":"11","author":"Sherwood","year":"2016","journal-title":"PLoS. One"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382600244X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382600244X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:32:54Z","timestamp":1786501974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S034403382600244X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":284,"alternative-id":["S034403382600244X"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156591","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquid biopsy in gynecologic cancers: Cellular origin to early detection and precision care","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156591","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156591"}}